Form 4: Health Catalyst CEO Sells Shares for Tax Obligations

Health Catalyst CEO Albert Benjamin disposed of 4,966 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Albert Benjamin, CEO and Director of Health Catalyst, Inc. (HCAT), disposed of 4,966 shares of common stock.
• The transaction occurred on March 2, 2026, at a price of $1.6599 per share.
• This sale was non-discretionary, mandated by the company's equity incentive plans to satisfy tax withholding obligations from the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Albert Benjamin directly beneficially owns 1,528,433 shares of common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was pre-planned.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a routine, non-discretionary 'sell to cover' for tax purposes, which is common for executive equity compensation and does not signal a change in company fundamentals or insider sentiment.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are a common and routine occurrence for executives receiving equity compensation, particularly Restricted Stock Units (RSUs), across all industries. They are typically not indicative of management's discretionary view on the company's future prospects but rather a mechanism to satisfy tax obligations upon vesting.

Related Party Transactions

• The transaction involves the disposition of shares by the CEO to cover tax withholding obligations related to the vesting of Restricted Stock Units, which are part of the company's equity incentive plans. This is a common form of compensation-related transaction between an executive and the company.

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a routine, non-discretionary transaction for tax purposes, not a discretionary sale indicating lack of confidence. The number of shares is relatively small compared to total outstanding shares and the CEO's remaining holdings.
• Employees: No direct impact mentioned.
• Customers/Suppliers/Creditors: No direct impact mentioned.

Key Dates

Recommendation

This Form 4 filing details a routine 'sell to cover' transaction by the CEO to satisfy tax obligations upon RSU vesting. It is a non-discretionary event and does not reflect a change in the CEO's investment conviction or the company's operational performance. Therefore, it provides no new fundamental information to warrant a change in investment recommendation, maintaining a 'hold' position based on existing company fundamentals.

Keywords

Health Catalyst, HCAT, Albert Benjamin, CEO, Director, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Tax Withholding, Equity Incentive Plan, Rule 10b5-1